Pharmaceutical

It will be held on 14th -15th March 2013 at Shanghai, industry and thought leaders will gather together to discuss new trends and innovation in the use of biomaterials in medical devices. From concept to market, biomaterials advances are increasing driving the industry; join us to learn all the latest.

Organized by CPhI Conferences, it will be held on May 23rd - 24th , 2013 in Shanghai, China, aiming to provide most valued and high-quality platform for all the industry stakeholders. Around 150 senior decision makers from relevant government organs/ industry associations, domestic and oversea top pharmaceutical manufacturers, Pharmaceutical distributors, temp-sensitive medical device companies, 3PL/4PL, cold chain technology/device suppliers (in packaging, refrigeration or temp-control, etc), software/ IT system providers, and etc, will gather together in Shanghai sharing ideas and experience. The heat topics, such as regulatory practices, industrial integration & cold chain process intensification, quality assurance upgrading and technology innovation will be put on the table for delegates to discussing the best practical model, exploring the right future direction, and discovering more business opportunities as well.

Co-organized by CCCMHPIE and UBM Conferences, it will be held on June 25th - 26th in Shanghai, China. As the supporting activity of CPhI China, the objective of the one and a half day forum is to provide communication and display platform for professionals in medical area, collecting the newest market information and provide various networking opportunities to discuss and showcase evolving pharmaceutical regulatory, market and technology under the support of globally vibrant speaker team line up from government and leading pharmaceutical companies. The forum is divided into three modules, Module A: International Regulatory Environment and Its Effect for Drug Exporting; Module B: Risk Management and On-Site Inspection; C: WHO Prequalification and International Procurement.

Start new, Strive to be Elite, inscribed by Dr. Kerong DAI, Academician from Chinese Academy of Engineering, Implantable and Interventional Medical Devices China Conference (IIMD China) ended with great success on 20th July in Shanghai. This conference has brought together the forefront of this industry, speakers from Food and Drug Administration, Shanghai Food and Drug Administration, Shanghai Ninth People’s Hospital, Nanjing General Hospital of Military Command PLA, Medtronic, Microport and Smith&Nephew and other business organizations get-together, discussing and sharing the latest technical results and policies and regulations. More than 100 delegates got involved. After the successful hosting of IIMD Conference in 2011, the 1st IIMD China (Shanghai) & the 2nd IIMD China (Beijing) , 3rd IIMD China 2013 will be held this 23rd -24th May in Shanghai, which is another must-attend event.

It will bring about 120+ key decision-makers from government agencies, generic and bio-pharma manufacturers in gathering for deeper discussing about the concerns and bottlenecks during the process of generics drug R&D, application, registration and production. Interactive topics will be diversified from the 3 perspectives: regulatory updates; process quality innovation and "Going-out & Introducing-in" R&D cooperation. This is an indispensable industry insights networking platform tailor-made for domestic & overseas generic-pharma professionals, which contribute a lot to the generic drug value-chain growth and know-how upgrading.

It will be held in Shanghai, China on 17th - 18th April, 2013. This conference is organized by CPhI Conferences and has brought together top-level industry executives from government & regulatory agencies (FDA, NIFDC), international pharma companies (Pfizer, Huahai, Haisun, Hengrui, NNE, Frontage, Sanovel), QbD/PAT companies (Malvern) etc. to discuss industry hot issues and provide communication platform for professionals who engaged in drug R&D and quality control.